Evolva Holding SA
SIX:EVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.3), the stock would be worth CHf0 (100% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | CHf0.95 |
0%
|
| 3-Year Average | 0.3 | CHf0 |
-100%
|
| 5-Year Average | 6.5 | CHf0 |
-100%
|
| Industry Average | 1.6 | CHf0 |
-100%
|
| Country Average | 2.3 | CHf0 |
-100%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
|
Evolva Holding SA
SIX:EVE
|
7.1m CHF | 0 | -8.1 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83.3B USD | 4 | 32.4 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13T JPY | 4.6 | 26.8 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.5B USD | 5.1 | 36.4 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.8 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
280.3B CNY | 1.6 | 21.3 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 4 | 24.4 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.4 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 6.7 | 61.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.6B USD | 1.8 | 15.6 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.9 | 17.5 |
Market Distribution
Other Multiples
Evolva Holding SA
Glance View
Evolva Holding SA is a biotech company, which engages in the research, development, manufacture, and commercialization of nutritional, healthcare, and wellness ingredients. The company is headquartered in Reinach, Basel-Landschaft and currently employs 68 full-time employees. The company went IPO on 2005-05-04. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The firm is focused on developing and increase the yield and efficiency of the production of various ingredients.
